Prevalence of metabolic syndrome in Brazilian adults in the last 10 years: a systematic review and meta-analysis

Abstract

Background A cluster of interconnected cardiometabolic risk factors characterizes metabolic Syndrome (MS). The prevalence of MS is increasing worldwide, but there is not a meta-analysis of this prevalence in the Brazilian population. We aimed to determine the prevalence of metabolic syndrome among adult general population in Brazil through a meta‑analysis study. Methods Original research studies were searched at PubMed, Scopus, Web of Science, and SciELO databases, from 2011 to 2021. We used the Joanna Briggs Institute tool to assess the quality of included studies. The random effect model was used to estimate the pooled prevalence of MS. Subgroup and meta-regression analysis were conducted for explored heterogeneity and used the Funnel Plot and Egger’s test to assess publication bias. The study was performed based on the criteria of Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA). Results The search in electronic databases identified 1598 records. From this total, 26 studies were eligible to be included in the final analysis. The overall pooled prevalence among the general population of Brazil was 33% with high heterogeneity observed. By gender, the prevalences were 26% in males and 38% in females. By criteria that was used to define MS, the prevalence were 31% in NCEP ATP III, 25% in JIS, 37% in IDF/NHLBI/AHA/WHF/IAS/IASO and 33% in IDF criteria. The prevalence in different habitat was 34% in urban, 15% in rural, 28% in quilombola and 37% in indigenous. In different regions was 37% in the South, 30% in Southeast, 38% in North, 31% in Northeast and 39% in Midwest. The pooled prevalence of MS with age was < 45 years: 43% and ≥ 45 years: 42% and the prevalence based on year of study implementation was 31% in 2015–2019, 35% in 2010–2014 and 28% in 2005–2009. There were no statistically significant differences between subgroups. Most of the studies showed high quality assessment criteria’s except adequate sample size criteria and many studies participants were not sampled in an appropriate way. Conclusions Our review indicates a high prevalence of MS in the healthy Brazilian adult population, when compared to others countries and with a world estimate.

Comparison of metabolic syndrome prevalence using three different definitions: A population-based study in Peru

“…Based on the standards of the ATPIII and WHO, it was found in our research that living in the highlands provided protection against metabolic syndrome as opposed to living in the jungle. This discovery aligns with the findings of a study performed in Brazil - urban living was connected with an increased risk of MetS versus rural living (28) . Additionally, a report in China discovered that city living correlated to a higher chance of MetS.…”

Association of Subclinical Hypothyroidism with Metabolic Syndrome in Young Adult Egyptians

“…The prevalence from different populations differs greatly. In adult Brazilians it was (33.0%) (11) , in United States adults it was (31.9%) in Mexican Americans and (23.8%) among whites, (21.6%) in African Americans and in people reporting an "other" race or ethnicity it was (20.3%) (12) . Different lifestyles, ethnicity, and even the definition used to diagnose MetS all contribute to different rates.…”

Exploring the Diagnosis of Immune-Related Genes in Metabolic Syndrome Based on Three Algorithms

“…MetS increases the risk of various diseases, such as type 2 diabetes, blood pressure, hypertension, atherosclerotic blood lipids, and fatty liver disease, which makes MetS a leading cause of morbidity and mortality worldwide [28,29]. A third of American adults have MetS [29,30]. The adult incidence of MetS in China has risen from 9.5% in 2002 to 18.7% in 2012 [31].…”